Laboratory detection of extended-spectrum β-lactamases (ESBLs) - The need for a reliable, reproducible method

Diagnostic Microbiology and Infectious Disease

Volumn 37, Issue 4, 2000, Pages 293-295

  Essack, S Y ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CEPHAMYCIN; CLAVULANIC ACID; PENICILLIN G; SULFONE; TEMOCILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM DETECTION; BACTERIUM ISOLATION; COST EFFECTIVENESS ANALYSIS; ENZYME ACTIVITY; LABORATORY DIAGNOSIS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; KLEBSIELLA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0034254073     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(00)00152-8     Document Type: Article

References (22)

1. Bonafede M., Rice L.B. Emerging antibiotic resistance. Journal of Laboratory Clinical Medicine. 130:1997;558-566.
2. Cormican M.G., Marshall S.A., Jones R.N. Detection of extended-spectrum β-lactamase (ESBL)-producing strains by Etest ESBL screen. Antimicrobial Agents and Chemotherapy. 34:1996;1880-1884.
3. Coudron P.F., Moland S.E., Sanders C.C. Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a veteran's medical centre, seek and you may find. Antimicrobial Agents and Chemotherapy. 35:1997;2593-2597.
4. Emery C.L., Weymouth L.A. Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical centre. Journal of Clinical Microbiology. 35:1997;2061-2067.
5. Jacobsen K.L., Cohen S.H., Inciardi J.F., King J.H., Lippert W.E., Iglesias T., Van Couwenberghe C.J. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I β-lactamase-producing organisms. Clin Infect Dis. 21:1995;1107-1113.
6. Jacoby G.A., Carreras I. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy. 34:1990;858-862.
7. Jacoby G.A., Medeiros A.A. More extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy. 35:1991;1697-1704.
8. Katsanis G.P., Spargo J., Ferraro M.J., Sutton L., Jacoby G.A. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. Journal of Clinical Microbiology. 32:1994;691-696.
9. Liu P.Y.F., Gur D., Hall L.M.C., Livermore D.M. Survey of the prevalence of β-lactamases amongst 1000 Gram-negative bacilli isolated consecutively at the Royal London Hospital. Journal of Antimicrobial Chemotherapy. 30:1992;429-447.
10. Livermore D.M. β-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews. 8:1995;557-584.
11. Moland E.S., Thomson K.S. Extended-spectrum β-lactamases of Enterobacteriaceae. Journal of Antimicrobial Chemotherapy. 33:1994;666-668.
12. Philippon A., Labia R., Jacoby G. Extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy. 33:1989;1131-1136.
13. Quinn J.P., Miyashiro D., Sahm D., Flamm R., Bush K. Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 33:1989;1451-1456.
14. Rasheed J.K., Jay C., Methcode B., Berkowitz F., Weigel L., Crellin J., Steward C., Hill B., Medeiros A.A., Tenover F.C. Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrobial Agents and Chemotherapy. 41:1997;647-653.
15. Rice L.B., Marshall S.H., Carais L.L., Sutton L., Jacoby G.A. Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum β-lactamase genes. Antimicrobial Agents and Chemotherapy. 37:1993;2760-2761.
16. Rice L.B., Willey S.H., Papanicolaou G.A., Medeiros A.A., Eliopoulos G.M., Moellering R.C., Jacoby G.A. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic care facility. Antimicrobial Agents and Chemotherapy. 34:1990;2193-2199.
17. Sanders C.C., Barry A.L., Washington J.A., Schubert C., Moland E.S., Traczewski M.M., Knapp C., Mulder R. Detection of the extended-spectrum β-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test. Antimicrobial Agents and Chemotherapy. 34:1996;2997-3001.
18. Sirot D. Extended-spectrum plasmid mediated β-lactamases. Journal of Antimicrobial Chemotherapy. 36:(Suppl. A):1995;19-34.
19. Thomson K.S., Sanders C.C. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae, comparison of the double-disk and three-dimensional tests. Antimicrobial Agents and Chemotherapy. 36:1992;1877-1882.
20. Vercauteren E., Descheemaker P., Leven M., Sanders C.C., Gousens H. Comparison of screening methods for detection of extended-spectrum β-lactamases and the prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. Antimicrobial Agents and Chemotherapy. 35:1997;2191-2193.
21. Wu S.W., Dornsbusch K., Gorannson E., Ransjo U., Kronvall G. Characterisation of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime. Journal of Antimicrobial Chemotherapy. 28:1991;389-397.
22. Wu S.W., Dornsbusch K., Norgren M., Kronvall G. Extended-spectrum β-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family. Journal of Antimicrobial Chemotherapy. 30:1992;3-16.